BlackRock Health Sciences Trust (BME)
NYSE NYSE Primary 
XFRA Summary
BME Chart
3 Closed-End Fund Buys In October 2025
The broader equity indexes continue to look strong, led by mega-cap tech, which has helped push the markets to all-time highs. With hitting new all-time highs, I continue to allow my cash pile to build up instead of putting it all to work at what looks like elevated levels. That said, I make some purchases every month to help grow cash flow over time and to capitalize on pockets of opportunity.
B&M profits slump splits analysts
Analysts struck a cautious but mildly constructive tone on B&M European Value Retail SA (LSE:BME) following its interim results, which confirmed a sharp year-on-year drop in profit but few surprises after two earlier pre-releases. The discount retailer posted first-half EBITDA of £191 million, down 30% year on year, on sales of £2.75 billion, up 4%.
B&M faces 'credibility crisis' after second profit warning, but some analysts see 'one off' error
B&M European Value Retail's (LSE:BME) second profit warning in as many weeks "erodes trust further", said analysts, with some saying it demands more questions than it answers. Deutsche Bank said the discounter is "facing a credibility crisis", after Monday's guidance downgrade came less than two weeks after a new 'Back to Basics' strategy was published.
BlackRock Health Sciences Trust (BME) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has BlackRock Health Sciences Trust ever had a stock split?
BlackRock Health Sciences Trust Profile
| NYSE Exchange | US Country |
Overview
The BlackRock Health Sciences Trust is a standout closed-end equity mutual fund that zeroes in on the dynamic and fast-growing health sciences sector. Its core objective revolves around generating high current income and ensuring capital appreciation for its investors. This is chiefly achieved through a diversified investment strategy that encompasses a wide array of healthcare companies. These companies span various segments including pharmaceuticals, biotechnology, hospital management, medical devices, and health insurance. By focusing on firms that are at the forefront of medical innovations and advancements, BlackRock Health Sciences Trust aims to tap into the lucrative opportunities presented by the expanding healthcare industry. A unique aspect of the trust is its covered call writing strategy, which plays a pivotal role in enhancing income while providing some level of downside protection. This strategic approach positions the trust as a valuable investment vehicle for those seeking to leverage the growth and dynamism of the healthcare sector. Leveraging the expertise and strategic asset management prowess of BlackRock, its parent organization and a global leader in investment management, BlackRock Health Sciences Trust offers investors expert insights and a disciplined investment approach.
Products and Services
- Investment in Healthcare Companies:
- High Current Income and Capital Appreciation:
- Covered Call Writing Strategy:
At its core, the BlackRock Health Sciences Trust invests in a diversified portfolio of healthcare companies. This encompasses entities across pharmaceuticals, biotechnology, hospital management, medical equipment, and health insurance. The trust aims to select companies that are instrumental in driving medical advancements and innovations, thereby capitalizing on the growth potential within the healthcare sector.
The primary goal of the trust is to generate high current income for its investors, alongside fostering capital appreciation. This dual-focus strategy is designed to offer investors a balanced portfolio with the potential for both steady income and growth, leveraging the steady and sometimes rapid advancements within the health sciences field.
A distinctive feature of the BlackRock Health Sciences Trust is its use of a covered call writing strategy. This strategy involves selling call options on a portion of the portfolio's securities. It serves to enhance the trust’s income potential, offering investors an opportunity to gain additional income from their investments. This strategic approach not only supplements the trust's earnings but also provides some level of protection against the downside, making it an attractive option for those looking to mitigate risk while investing in the high-potential healthcare sector.
Contact Information
